Fourier Transform Infrared Spectroscopy Is a New Option for Outbreak Investigation: a Retrospective Analysis of an Extended-Spectrum-Beta-Lactamase-Producing Klebsiella Pneumoniae Outbreak in a Neonatal Intensive Care Unit
Overview
Authors
Affiliations
The IR Biotyper is a new automated typing system based on Fourier-transform infrared (FT-IR) spectroscopy that gives results within 4 h. We aimed (i) to use the IR Biotyper to retrospectively analyze an outbreak of extended-spectrum beta-lactamase-producing (ESBL-KP) in a neonatal intensive care unit and to compare results to BOX-PCR and whole-genome sequencing (WGS) results as the gold standard and (ii) to assess how the cutoff values used to define clusters affect the discriminatory power of the IR Biotyper. The sample consisted of 18 isolates from 14 patients. Specimens were analyzed in the IR Biotyper using the default analysis settings, and spectra were analyzed using OPUS 7.5 software. The software contains a feature that automatically proposes a cutoff value to define clusters; the cutoff value defines up to which distance the spectra are considered to be in the same cluster. Based on FT-IR, the outbreak represented 1 dominant clone, 1 secondary clone, and several unrelated clones. FT-IR results, using the cutoff value generated by the accompanying software after 4 replicates, were concordant with WGS for all but 1 isolate. BOX-PCR was underdiscriminatory compared to the other two methods. Using the cutoff value generated after 12 replicates, the results of FT-IR and WGS were completely concordant. The IR Biotyper can achieve the same typeability and discriminatory power as genome-based methods. However, to attain this high performance requires either previous, strain-dependent knowledge about the optimal technical parameters to be used or validation by a second method.
Franconi I, Fais R, Giordano C, Tuvo B, Stani C, Tavanti A J Fungi (Basel). 2025; 11(1).
PMID: 39852459 PMC: 11767175. DOI: 10.3390/jof11010040.
Epchtien R, Temkin E, Lurie-Weinberger M, Kastel O, Keren-Paz A, Schwartz D Microbiol Spectr. 2025; 13(2):e0207924.
PMID: 39807863 PMC: 11792496. DOI: 10.1128/spectrum.02079-24.
Temkin E, Bechor M, Lurie-Weinberger M, Keren-Paz A, Chen D, Lugassy C Emerg Infect Dis. 2024; 31(1):66-74.
PMID: 39714269 PMC: 11682801. DOI: 10.3201/eid3101.240722.
Unlocking the Potential of Silver Nanoparticles: From Synthesis to Versatile Bio-Applications.
Almatroudi A Pharmaceutics. 2024; 16(9).
PMID: 39339268 PMC: 11435049. DOI: 10.3390/pharmaceutics16091232.
Lepine N, Bras-Cachinho J, Couratin E, Lemaire C, Chaufour L, Junchat A Front Microbiol. 2024; 15:1455945.
PMID: 39323891 PMC: 11422107. DOI: 10.3389/fmicb.2024.1455945.